We are live on
!
Find out more
MVG
Madrona Venture Group Portfolio holdings
AUM
$22.1M
1-Year Est. Return
86.9%
This Fund
S&P 500
This Quarter
Est. Return
+2.38%
1 Year Est. Return
+86.9%
3 Year Est. Return
+233.1%
5 Year Est. Return
+22.16%
10 Year Est. Return
–
AUM
$617M
AUM Growth
+$73.1M
(+13%)
Cap. Flow
+$55.6M
Cap. Flow
% of AUM
9.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
–
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nautilus Biotechnolgy
NAUT
|
+$65.2M |
| 2 |
UiPath
PATH
|
+$63.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$58.2M |
| 2 |
ACCD
Accolade Inc
ACCD
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 92.25% |
| 2 | Healthcare | 7.75% |
| 3 | Industrials | 0% |
Similar funds
NCM
VCG
PIM
SWM
SM
MIG
ICM
CI
Madrona Venture Group's Q2 2021 Portfolio in Review
As of Q2 2021, Madrona Venture Group held 4 positions worth $617M, up 13% from $544M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Madrona Venture Group deployed $55.6M of net new capital in Q2 2021, opening 2 new positions. Its largest new stake was Nautilus Biotechnolgy: 6,020,770 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 92% of assets, down from 97% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Snowflake, an estimated $58.2M trimmed.
- Madrona Venture Group's largest Q2 2021 buy was Nautilus Biotechnolgy: 6,020,770 shares worth $47.8M.
- Madrona Venture Group's biggest Q2 2021 reduction was Snowflake, cutting an estimated $58.2M.
- Madrona Venture Group fully exited Accolade Inc in Q2 2021, selling an estimated $15.1M.
- Madrona Venture Group's ten largest holdings make up 100% of its $617M portfolio in Q2 2021.
- Madrona Venture Group opened 2 new positions and closed 1 in Q2 2021.
- Madrona Venture Group's portfolio value rose 13% quarter-over-quarter to $617M.
Based on Madrona Venture Group's 13F filing for Q2 2021, filed 15 Oct 2021.